AU7766900A - Nicotinyl aspartyl ketones as inhibitors of caspase-3 - Google Patents

Nicotinyl aspartyl ketones as inhibitors of caspase-3

Info

Publication number
AU7766900A
AU7766900A AU77669/00A AU7766900A AU7766900A AU 7766900 A AU7766900 A AU 7766900A AU 77669/00 A AU77669/00 A AU 77669/00A AU 7766900 A AU7766900 A AU 7766900A AU 7766900 A AU7766900 A AU 7766900A
Authority
AU
Australia
Prior art keywords
nicotinyl
caspase
inhibitors
aspartyl
ketones
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU77669/00A
Other languages
English (en)
Inventor
Cameron Black
Erich L Grimm
Elise Isabel
Johanne Renaud
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Frosst Canada and Co
Original Assignee
Merck Frosst Canada and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Frosst Canada and Co filed Critical Merck Frosst Canada and Co
Publication of AU7766900A publication Critical patent/AU7766900A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • C07D213/82—Amides; Imides in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Vascular Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU77669/00A 1999-10-13 2000-10-11 Nicotinyl aspartyl ketones as inhibitors of caspase-3 Abandoned AU7766900A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US15934899P 1999-10-13 1999-10-13
US60159348 1999-10-13
PCT/CA2000/001196 WO2001027085A1 (fr) 1999-10-13 2000-10-11 Utilisation de comme inhibiteurs de la caspase-3 nicotinyl aspartyl ketones as inhibitors of caspase-3

Publications (1)

Publication Number Publication Date
AU7766900A true AU7766900A (en) 2001-04-23

Family

ID=22572201

Family Applications (1)

Application Number Title Priority Date Filing Date
AU77669/00A Abandoned AU7766900A (en) 1999-10-13 2000-10-11 Nicotinyl aspartyl ketones as inhibitors of caspase-3

Country Status (3)

Country Link
AU (1) AU7766900A (fr)
CA (1) CA2386411A1 (fr)
WO (1) WO2001027085A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6878743B2 (en) 2001-09-18 2005-04-12 Sunesis Pharmaceuticals, Inc. Small molecule inhibitors of caspases
WO2004014843A1 (fr) * 2002-08-09 2004-02-19 Takeda Chemical Industries, Ltd. Composés amino substitués et utilisation de ces composés
WO2007011760A2 (fr) * 2005-07-15 2007-01-25 Kalypsys, Inc. Inhibiteurs de la kinesine mitotique
IT1392238B1 (it) * 2008-12-02 2012-02-22 Fond Santa Lucia Uso della caspasi-3 per la malattia dell'alzheimer
US11401370B2 (en) 2018-02-26 2022-08-02 Nippon Kayaku Kabushiki Kaisha Base proliferating agent, and base-reactive resin composition containing said base proliferating agent

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ330451A (fr) * 1996-09-12 2000-01-28 Idun Pharmaceuticals Inc
ATE295177T1 (de) * 1998-03-16 2005-05-15 Cytovia Inc Dipeptid kaspase inhibitoren und deren verwendung
DE69939689D1 (de) * 1998-03-19 2008-11-20 Vertex Pharma Caspase inhibitoren

Also Published As

Publication number Publication date
WO2001027085A1 (fr) 2001-04-19
CA2386411A1 (fr) 2001-04-19

Similar Documents

Publication Publication Date Title
AU2002250394A1 (en) Rho-kinase inhibitors
AU2002245709A1 (en) Rho-kinase inhibitors
AU2001258771A1 (en) -secretase inhibitors
HK1046899A1 (en) Inhibitors of aspartyl protease
AU2001241078A1 (en) Alpha-amylase activity inhibitors
HUP0201295A3 (en) Peptidyl heterocyclic ketones useful as tryptase inhibitors
AU6111000A (en) Inhibitors of viral helcase
AU2001285750A1 (en) Urokinase inhibitors
AU2002216314A1 (en) Heterocyclic angiogenesis inhibitors
AU5619400A (en) Statine-derived tetrapeptide inhibitors of beta-secretase
AU2002211662A1 (en) Nf-kappab inhibitors
AU2001243615A1 (en) Secure tracking of articles
AU1488501A (en) Methods of inhibiting metastasis
AU7126900A (en) Enzyme inhibitors
AUPQ629000A0 (en) Inhibition of fungi
AU3235100A (en) Prothease inhibitors
GB9924522D0 (en) Enzyme inhibitors
AU7766900A (en) Nicotinyl aspartyl ketones as inhibitors of caspase-3
GB0030284D0 (en) Enzyme inhibitors
AU4369000A (en) Inhibition of complement action
AU1474801A (en) Protease inhibitors
AU4066900A (en) Protease inhibitors
AU3888200A (en) Protease inhibitors
AU1474701A (en) Protease inhibitors
AU1474601A (en) Protease inhibitors

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase